Actually, there is no telemonitoring program that includes newborns or infants with congenital heart disease awaiting cardiac intervention. This is a vulnerable period, prone to clinical complications, rehospitalization, parental stress, and requires monitoring with clinical and therapeutic optimization. The aim of the study is to assess the feasibility and acceptability of monitoring newborns and infants with congenital heart disease awaiting cardiac surgery using the Blue-Line home telemonitoring program.
Newborns and/or infants aged 0 to 12 months inclusive at the time of diagnosis.
With congenital heart disease as defined in the ICD-11 classification.
Waiting for an intervention by cardiac surgery or interventional catheterization.
Free, informed consent signed by the holder(s) of parental authority.
Short-term vital prognosis
Clinical situation identified at the M3C RCP that contraindicates a return home
Family situation identified at the M3C RCP as contra-indicating a return home
Extra-cardiac co-morbidities requiring hospitalisation independent of the heart disease (e.g. severe renal failure, neurological deficit, complex immune deficiency, etc.).